# Sodium Bicarbonate Exercise Performance Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/sodium-bicarbonate-exercise-performance-meta-analysis-evidence-review
Category: evidence-review
Summary: Sodium Bicarbonate Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this 
Last reviewed: 2026-06-16
Reviewed by: Migaku Evidence Review
# Sodium Bicarbonate Exercise Performance Meta-analysis: What the Evidence Says

## Quick Answer

Sodium Bicarbonate Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of sodium bicarbonate, cholecalciferol, and protein supplementation interventions on muscle mass and metabolic disturbances in patients with chronic kidney disease: a systematic review and network meta-analysis | systematic review | 1 | 2026-04-08 | 10.3389/fnut.2026.1698991 |
| A comprehensive review of the physiology and evidence base to guide the use of ergogenic and medical supplements for enhanced cycling performance | narrative review | 3 | 2026-02-13 | 10.1080/15502783.2026.2630487 |

## What The Sources Report

- 6 7 8 9 10 7 Chronic Kidney Disease (CKD) is a major global health issue, and alterations in patients' nutritional status, body composition, and muscle mass are closely associated with its morbidity, mortality, and quality of life. [Leng Shuilian (2026); evidence level 1]
- Among individuals with CKD, the prevalence of sarcopenia increases from approximately 10% in non-dialysis-dependent patients to 37% in those with End-Stage Kidney Disease (ESKD), and its presence is significantly associated with reduced quality of life, major adverse cardiovascular events, and all-cause mortality. [Leng Shuilian (2026); evidence level 1]
- A growing body of evidence supports the use of supplements to enhance cycling performance. [Rowland Andrew (2026); evidence level 3]
- These supplements are broadly classified as ergogenic (direct) supplements, which acutely enhance performance, and medical (indirect) supplements that enable consistent training and improved physical resilience. [Rowland Andrew (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For sodium bicarbonate exercise performance meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Leng Shuilian (2026). Effects of sodium bicarbonate, cholecalciferol, and protein supplementation interventions on muscle mass and metabolic disturbances in patients with chronic kidney disease: a systematic review and network meta-analysis. DOI: 10.3389/fnut.2026.1698991. PMCID: PMC13099916. PMID: 42027563. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13099916/
- Rowland Andrew (2026). A comprehensive review of the physiology and evidence base to guide the use of ergogenic and medical supplements for enhanced cycling performance. DOI: 10.1080/15502783.2026.2630487. PMCID: PMC12912213. PMID: 41685663. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12912213/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.